126 related articles for article (PubMed ID: 31306036)
1. Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
Hanna TP; Nguyen P; Pater J; O'Callaghan CJ; Mittmann N; Earle CC; Tu D; Jonker D; Hay AE
J Oncol Pract; 2019 Sep; 15(9):e807-e824. PubMed ID: 31306036
[TBL] [Abstract][Full Text] [Related]
2. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes.
Hay AE; Pater JL; Corn E; Han L; Camacho X; O'Callaghan C; Chong N; Bell EN; Tu D; Earle CC
Clin Trials; 2019 Feb; 16(1):14-17. PubMed ID: 30466310
[TBL] [Abstract][Full Text] [Related]
4. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
Tappenden P; Jones R; Paisley S; Carroll C
Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
[TBL] [Abstract][Full Text] [Related]
6. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation.
Dundar Y; Bagust A; Dickson R; Dodd S; Green J; Haycox A; Hill R; McLeod C; Walley T
Health Technol Assess; 2007 Jan; 11(1):1-90. PubMed ID: 17181984
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments.
Mortimer D; Bosch M; Mckenzie JE; Turner S; Chau M; Ponsford JL; Knott JC; Gruen RL; Green SE
Implement Sci; 2018 Dec; 13(1):147. PubMed ID: 30518430
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.
Wijeysundera HC; Machado M; Wang X; Van Der Velde G; Sikich N; Witteman W; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
Value Health; 2010 Dec; 13(8):915-21. PubMed ID: 21091970
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment.
Starling N; Tilden D; White J; Cunningham D
Br J Cancer; 2007 Jan; 96(2):206-12. PubMed ID: 17242694
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Chen J; Bhatt DL; Dunn ES; Shi C; Caro JJ; Mahoney EM; Gabriel S; Jackson JD; Topol EJ; Cohen DJ
Value Health; 2009 Sep; 12(6):872-9. PubMed ID: 19490556
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Greenhalgh J; Bagust A; Boland A; Fleeman N; McLeod C; Dundar Y; Proudlove C; Shaw R
Health Technol Assess; 2009 Oct; 13 Suppl 3():49-54. PubMed ID: 19846029
[TBL] [Abstract][Full Text] [Related]
15. Integration of primary contact physiotherapists in the emergency department for individuals presenting with minor musculoskeletal disorders: Protocol for an economic evaluation.
Gagnon R; Hébert LJ; Guertin JR; Berthelot S; Desmeules F; Perreault K
PLoS One; 2023; 18(9):e0277369. PubMed ID: 37708179
[TBL] [Abstract][Full Text] [Related]
16. Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada.
de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
Value Health; 2017 Mar; 20(3):345-356. PubMed ID: 28292479
[TBL] [Abstract][Full Text] [Related]
17. Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.
Hoch JS; Hay A; Isaranuwatchai W; Thavorn K; Leighl NB; Tu D; Trenaman L; Dewa CS; O'Callaghan C; Pater J; Jonker D; Chen BE; Mittmann N
BMC Cancer; 2019 Jun; 19(1):552. PubMed ID: 31174497
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness and lung cancer clinical trials.
Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
